THREAT MODEL: COVID 🦠
for June 25th, 2026
by independent journalist @violetblue

- France announces first confirmed #Ebola case

- Third case of #BirdFlu reported in #Australia

- #Aotearoa #NewZealand insists it is "well prepared" for pandemics (it's not)

- #Screwworm detections now up to 20 (TX)

- JAMA journal publishes #Covid vaccine booster study blocked by Bhattacharya

- @thesicktimes reports on Covid pre-exposure prophylactic drug #Xocova , now approved by the US #FDA

- @publichealthaction.bsky.social and @AirSupportProject to host a virtual talk on the #PrecautionaryPrinciple on June 28th

- Virtual Pride variety show on June 30th hosted by The Sick Times; Calling Up Justice's virtual Pride July 4th-5th

...and much more.

✨THREAT MODEL is free to read -- please help keep it accessible to all by becoming a patron, even $1 a month makes a difference!✨

https://www.patreon.com/violetblue/posts/pandemic-roundup-162031691

#ThreatModel #ThreatModelCovid #ThreatModelNewsletters #VioletBlue #COVIDnews #PublicHealth #CovidIsNotOver

(Breaking)
Japan's Ministry of Health, Labour and Welfare approves Xocova for preventive administration against covid symptom onset
(No details yet, and this seems to be prevention of symptoms rather than preventing infection itself. Positive news is positive news, though!)

JP article (really just the announcement):
https://www.47news.jp/13940194.html

#CovidIsntOver #covid #CovidNews #CovidJapan #xocova

【速報】コロナ薬「ゾコーバ」の予防投与を了承

 新型コロナウイルス感染症の飲み薬「ゾコーバ」を巡り、厚生労働省の専門部会は2日、発症を防ぐために事前 ...

47NEWS

#补个来源

#上海医药 获得抗新冠病毒口服药物#Ensitrelvir 独家进口及经销权
https://company.cnstock.com/company/scp_gsxw/202212/4997431.htm

新冠口服药!#盐野义 3CL蛋白酶抑制剂#Xocova 获日本紧急批准:治疗轻中度COVID-19!
https://news.bioon.com/article/3eade499910e.html

上海医药获得抗新冠病毒口服药物Ensitrelvir独家进口及经销权-上市公司-上海证券报·中国证券网

  上海医药12月23日晚间公告称,公司全资子公司上海控股有限公司(简称“上药控股”)与平安盐野义就抗新冠病毒口服药物Ensitrelvir的进口品签订了《进口分销协议》,上药控股将作为Ensitrelvir进口品在中国大陆地区的独家进口商和经销商。同时,上海医药与平安盐野义就更广泛的新药和仿制药产品在更深远的合作层面签订了《战略合作框架协议》。  公告

» 鹽野義與中國企業簽訂新冠口服藥進口分銷協議 https://t.co/kWqePBZY2T // 鹽野義和中國企業的合資公司“平安鹽野義”與大型製藥集團“上海醫藥”的子公司簽訂了協議。在中國獲批後,該子公司將獨家負責把 #Xocova 進口至中國並銷售給醫藥品批發商。
盐野义与中国企业签订新冠口服药进口分销协议

  【共同社12月24日电】日本盐野义制药公司23日就新冠口服药“Xocova”表示,与中国当地企业签订了进口和在华销售的协议。面向在中国的新药上市许可申请,已向相关部门提交资料。盐野义将趁着在日本紧

KYODO NEWS+